As of May 30, 2026, the three largest insider holders of INCY are Bros. Advisors Lp Baker (Director, 28.19Mn shares), Herve Hoppenot (Special Advisor To The Ceo, 326.80K shares), Pablo J Cagnoni (President, Rd, 234.80K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Edmund Harrigan | - | 21,122 | 0 | 02 Apr, 2026 |
| Wendy L Dixon | - | 17,768 | 0 | 04 Apr, 2022 |
| Pablo J Cagnoni | President, Rd | 234,800 | 0 | 19 Mar, 2026 |
| Otis W Brawley | - | 11,252 | 0 | 12 Jun, 2025 |
| Jean Jacques Bienaime | - | 20,841 | 0 | 12 Jun, 2025 |
| Paula J Swain | Evp, Human Resources | 106,482 | 0 | 16 Jul, 2025 |
| Bros. Advisors Lp Baker | - | 0 | 28,188,718 | 02 Apr, 2026 |
| Jacqualyn A Fouse | - | 19,326 | 0 | 12 Jun, 2025 |
| Paul J Clancy | - | 23,741 | 0 | 02 Apr, 2026 |
| William Meury | Chief Executive Officer | 161,101 | 0 | 17 Apr, 2026 |
| Herve Hoppenot | Special Advisor To The Ceo | 326,803 | 0 | 10 Dec, 2025 |
| Barry P Flannelly | Evp General Manager Us | 35,149 | 0 | 17 Jul, 2025 |
| Yao Wenqing | Evp, Head Of Discovery Chem | 98,575 | 0 | 07 Jul, 2021 |
| Katherine A High | - | 13,341 | 0 | 12 Jun, 2025 |
| Paul Trower | Principal Accounting Officer | 32,268 | 0 | 05 Jan, 2022 |
| Vijay K Iyengar | Evp, Gmapps | 40,540 | 0 | 17 Jul, 2025 |
| Steven H Stein | Cmo Head Of Late Stage Dev. | 73,252 | 0 | 17 Apr, 2026 |
| Maria E Pasquale | Evp General Counsel | 69,724 | 0 | 18 Jul, 2023 |
| Dashyant Dhanak | Evp Chief Scientific Officer | 58,968 | 0 | 18 Jul, 2023 |
| Jonathan Elliott Dickinson | Evp, General Manager, Europe | 36,390 | 0 | 16 Sep, 2024 |
| Michael James Morrissey | Evp, Head Of Tech. Operations | 34,065 | 0 | 04 Feb, 2026 |
| Thomas Tray | Principal Accounting Officer | 22,973 | 0 | 22 Dec, 2025 |
| Susanne Schaffert | - | 7,389 | 0 | 12 Jun, 2025 |
| Sheila A. Denton | Evp General Counsel | 26,569 | 0 | 19 Nov, 2025 |
| Matteo Trotta | Evp, Gm, Dermatology Us | 14,882 | 0 | 26 Mar, 2026 |
| Lee Heeson | Evp, Head Of Incyte Intl | 38,041 | 0 | 04 Feb, 2026 |
| Mohamed Khairie Issa | Evp, Head Of Us Oncology | 66,132 | 0 | 08 Jan, 2026 |
| Patrick A Mayes | Evp Chief Scientific Officer | 60,011 | 0 | 12 Dec, 2025 |
| Ramitpal K Basi | Evp, Human Resources | 6,506 | 0 | 27 Aug, 2025 |
| David H Gardner | Evp, Chief Strategy Officer | 9,429 | 0 | 24 Sep, 2025 |
| Richard A. Hoffman | Evp General Counsel | 9,466 | 0 | 03 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | William Meury | Common Stock | A | 125,000 | $0.00 | 161,101 | D | M |
| 15 Apr, 2026 | Steven H Stein | Common Stock | A | 39,049 | $0.00 | 73,252 | D | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 2,818,039 | I | A |
| 31 Mar, 2026 | Paul J Clancy | Common Stock | A | 265 | $94.12 | 23,741 | D | A |
| 31 Mar, 2026 | Edmund Harrigan | Common Stock | A | 269 | $94.12 | 21,122 | D | A |
| 31 Mar, 2026 | Bros. Advisors Lp Baker | Common Stock | A | 421 | $0.00 | 28,188,718 | I | A |
| 25 Mar, 2026 | Matteo Trotta | Common Stock | D | 537 | $92.23 | 14,882 | D | F |
| 25 Mar, 2026 | Matteo Trotta | Common Stock | D | 537 | $92.23 | 14,882 | D | F |
| 25 Mar, 2026 | Matteo Trotta | Common Stock | D | 537 | $92.23 | 14,882 | D | F |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 7,166 | $61.18 | 241,966 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | A | 11,501 | $64.25 | 253,467 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Common Stock | D | 18,667 | $94.24 | 234,800 | D | S |
| 17 Mar, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 7,166 | $0.00 | 9,102 | D | M |
| 17 Mar, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 11,501 | $0.00 | 32,910 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 13,093 | $61.76 | 247,893 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | A | 5,575 | $61.18 | 253,468 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Common Stock | D | 18,668 | $100.91 | 234,800 | D | S |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 13,093 | $0.00 | 7,182 | D | M |
| 19 Feb, 2026 | Pablo J Cagnoni | Employee Stock Option (right to buy) | D | 5,575 | $0.00 | 16,268 | D | M |
| 02 Feb, 2026 | Michael James Morrissey | Common Stock | D | 185 | $102.67 | 34,065 | D | F |